Evidence map›Paper›PMID 22228743›Full record

Trial reportDiabetes care2012

Effect of α-lipoic acid on platelet reactivity in type 1 diabetic patients.

Roberto Mollo, Francesco Zaccardi, Giancarla Scalone, Giuseppe Scavone, Paola Rizzo, Eliano Pio Navarese, Andrea Manto, Dario Pitocco, Gaetano Antonio Lanza, Giovanni Ghirlanda and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Significance of 8-iso-PGFAmerican heart journal plus : cardiology research and practice · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roberto MolloDepartment of Cardiovascular Medicine, Catholic University, Rome, Italy.
Francesco Zaccardi
Giancarla Scalone
Giuseppe Scavone
Paola Rizzo
Eliano Pio Navarese
Andrea Manto
Dario Pitocco
Gaetano Antonio Lanza
Giovanni Ghirlanda
Filippo Crea

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveType 1 diabetes is associated with increased platelet reactivity. We investigated whether α-lipoic acid (ALA) has any effect on platelet reactivity in these patients. RESEARCH DESIGN AND

methodsWe randomly assigned 51 type 1 diabetic patients to ALA (600 mg once daily) or placebo for 5 weeks. Platelet reactivity was evaluated by the PFA-100 method and by measuring CD41 and CD62 platelet expression. C-reactive protein (CRP) and 8-iso-prostaglandin F2α serum levels also were measured.

resultsBaseline variables were similar in the two groups. After treatment, closure time was longer (P = 0.006) and CD62P platelet expression was lower, both before (P = 0.002) and after (P = 0.009) ADP stimulation in the ALA group compared with the placebo group. CRP and 8-iso-prostaglandin F2α levels showed no differences between the two groups.

conclusionsOur data show that ALA reduces measures of platelet reactivity ex vivo in type 1 diabetic patients, independently of antioxidant or anti-inflammatory effects.

Indexed as

AdultAntioxidantsBlood PlateletsC-Reactive ProteinDiabetes Mellitus, Type 1DinoprostFemaleHumansMaleMiddle AgedPlatelet Membrane Glycoprotein IIbP-SelectinThioctic Acid8-epi-prostaglandin F2alphaAntioxidantsC-Reactive ProteinDinoprostPlatelet Membrane Glycoprotein IIbP-SelectinThioctic Acid

Identifiers

PMID22228743
PMCPMC3263886

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.